Impact of MS disease-modifying therapies on antibody and T cell responses following COVID-19 vaccination

被引：0
作者：
Sabatino, J. [1 ]
Rowles, W. [1 ]
Mittl, K. [1 ]
Mcpolin, K. [1 ]
Rajan, J. [2 ]
Zamecnik, C. [1 ]
Zhao, C. [1 ]
Dandekar, R. [1 ]
Alvarenga, B. [1 ]
Loudermilk, R. [1 ]
Gerungan, C. [1 ]
Spencer, C. [1 ]
Sagan, S. [1 ]
Augusto, D. [1 ]
Alexander, J. [1 ]
Ho, B. [1 ]
Hollenbach, J. [1 ]
Hollenbach, J. [1 ]
Zamvil, S. [1 ]
Bove, R. [1 ]
机构：
[1] Univ Calif San Francisco, Neurol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Med, San Francisco, CA 94143 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P979
引用
收藏
页码：795 / 795
页数：1
相关论文
共 50 条
  • [41] Immune response to COVID-19 vaccines in patients with multiple sclerosis treated with disease-modifying therapies
    Brola, Waldemar
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2023, 57 (01) : 11 - 13
  • [42] Humoral and T cell responses to COVID-19 vaccination in IBD
    Zhang, E.
    Bond, K.
    Nguyen, O.
    Allen, L.
    Kedzierski, L.
    Kedzierka, K.
    Christensen, B.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I190 - I191
  • [43] Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies
    Baba, Cavid
    Ozcelik, Sinem
    Kaya, Ergi
    Samedzada, Ulvi
    Ozdogar, Asiye Tuba
    Cevik, Sumeyye
    Dogan, Yavuz
    Ozakbas, Serkan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [44] Cerebral Hemodynamic Responses to Disease-Modifying and Curative Sickle Cell Disease Therapies
    Aumann, Megan A.
    Richerson, Wesley
    Song, Alexander K.
    Martin, Dann
    Davis, L. Taylor
    Davis, Samantha M.
    Milner, Lauren L.
    Kassim, Adetola A.
    Debaun, Michael R.
    Jordan, Lori C.
    Donahue, Manus J.
    NEUROLOGY, 2025, 104 (01)
  • [45] Humoral- and T-Cell Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
    Tortorella, Carla
    Aiello, Alessandra
    Gasperini, Claudio
    Agrati, Chiara
    Castilletti, Concetta
    Ruggieri, Serena
    Meschi, Silvia
    Matusali, Giulia
    Colavita, Francesca
    Farroni, Chiara
    Cuzzi, Gilda
    Cimini, Eleonora
    Tartaglia, Eleonora
    Vanini, Valentina
    Prosperini, Luca
    Haggiag, Shalom
    Galgani, Simona
    Quartuccio, Maria Esmeralda
    Salmi, Andrea
    Repele, Federica
    Altera, Anna Maria Gerarda
    Cristofanelli, Flavia
    D'Abramo, Alessandra
    Bevilacqua, Nazario
    Corpolongo, Angela
    Puro, Vincenzo
    Vaia, Francesco
    Capobianchi, Maria Rosaria
    Ippolito, Giuseppe
    Nicastri, Emanuele
    Goletti, Delia
    NEUROLOGY, 2022, 98 (05) : E541 - E554
  • [46] COVID-19 ANTIBODY RESPONSES IN RENAL TRANSPLANT PATIENTS FOLLOWING BOOSTER VACCINATION
    Lavery, Grace
    Floyd, Lauren
    Solomon, Laurie
    Dhaygude, Ajay
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I728 - I728
  • [47] Impact of disease-modifying drugs on the severity of COVID-19 infection in multiple sclerosis patients
    Rostami Mansoor, Sahar
    Ghasemi-Kasman, Maryam
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1314 - 1319
  • [48] COVID-19 and Disease-Modifying Anti-rheumatic Drugs
    Kristin M. D’Silva
    Zachary S. Wallace
    Current Rheumatology Reports, 2021, 23
  • [49] IMPACT OF SLEEP AND TIMING OF VACCINATION ON NEUTRALIZING ANTIBODY RESPONSES TO THE COVID-19 VACCINE
    Prather, Aric
    Dutcher, Ethan
    Mason, Ashley
    Robinson, James
    Drury, Stacy
    Hecht, Frederick
    Epel, Elissa
    SLEEP, 2024, 47
  • [50] Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis
    Etemadifar, Masoud
    Nouri, Hosein
    Pitzalis, Maristella
    Idda, Maria Laura
    Salari, Mehri
    Baratian, Mahshid
    Mahdavi, Sepide
    Abhari, Amir Parsa
    Sedaghat, Nahad
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09) : 986 - 994
12345